♥️God, Family & Love Animals, Trump Q & Anon Fan, Hoping & Praying for a Better World🙏Here to Learn, Share and Help Wake Up Others💖WWG1WGA

"Chemotherapeutic Drugs are the Only Classification of Drugs that the Prescribing Doctor Gets a Direct Cut Of."

"The only reason Chemotherapy is used is because Doctors make Money from it."

"It Doesn't Work 97% of the Time."

@HATSTRUTH 🎩

♥️God, Family & Love Animals, Trump Q & Anon Fan, Hoping & Praying for a Better World🙏Here to Learn, Share and Help Wake Up Others💖WWG1WGA

In response Carole Parnell to her Publication

A recent survey of physicians revealed that 88.3% of doctors would refuse chemotherapy for their own cancer treatment. This revelation raises important questions about the efficacy of chemotherapy, considering the 5-year survival rate for patients is only 2.1%. Many oncologists continue to offer chemotherapy as the "standard of care," despite its limitations.

With so much skepticism from within the medical community, patients are left to wonder whether there might be alternative treatments worth exploring. Dr. Seyfried, for example, suggests protocols like fasting and using Ivermectin as an alternative approach. These protocols, though unconventional, have shown promising results.

The current medical landscape surrounding cancer treatment is ripe for change. By questioning the status quo, we open the door to exploring alternative methods that could lead to better outcomes for patients worldwide. 💉❓

MD's offer this treatment here is how it goes.....MD buy the chemo for a small price.....sell to their patients for what ever they want...last time I checked it was 60-80% of the purchase price...and MD makes his profit.....Chemo causes cancer and the entire Medical system continues to make money....This is a fact I know this first hand....the whole system makes me sick.....

In response Carole Parnell to her Publication

Only people mentioned by @Robino in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Robin Oxman, click on at the bottom under it